Group 1 - The Pennant Group, Inc. (PNTG) shares have increased by 8.8% over the past four weeks, closing at $24.01, with a mean price target of $33.6 indicating a potential upside of 39.9% [1] - The mean estimate consists of five short-term price targets with a standard deviation of $5.13, where the lowest estimate is $28.00 (16.6% increase) and the highest is $40.00 (66.6% increase) [2] - Analysts show strong agreement in revising earnings estimates higher, which correlates with potential stock price movements, as the Zacks Consensus Estimate for the current year has increased by 3.3% over the past month [11][12] Group 2 - PNTG holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, indicating a strong potential upside [13] - While consensus price targets are often viewed as important, they should be approached with skepticism as they may not reliably indicate actual stock price movements [10][14] - Analysts' price targets can be influenced by business relationships, leading to potentially inflated estimates, but a low standard deviation among targets suggests a consensus on price direction [8][9]

Group 1 - VAREX IMAGING (VREX) shares have increased by 53.7% in the past four weeks, closing at $11.45, with a mean price target of $16.75 indicating a potential upside of 46.3% [1] - The average price targets range from a low of $10.00 to a high of $23.00, with a standard deviation of $5.38, suggesting variability in analyst estimates [2] - Analysts have shown strong agreement in revising earnings estimates higher, with a 59.5% increase in the Zacks Consensus Estimate for the current year, indicating positive earnings prospects [11][12] Group 2 - VREX holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, which supports the stock's potential upside [13] - While price targets can be misleading, the direction implied by the consensus price target appears to be a useful guide for potential price movement [14]

Core Viewpoint - Payoneer Global Inc. (PAYO) shows potential for significant upside, with a mean price target of $9.56 indicating a 41.4% increase from its current price of $6.76 [1] Price Targets and Analyst Estimates - The mean estimate consists of nine short-term price targets with a standard deviation of $1.67, suggesting variability in analyst predictions [2] - The lowest estimate is $7.00, indicating a 3.6% increase, while the highest estimate is $12.00, suggesting a 77.5% increase [2] - A low standard deviation indicates a high degree of agreement among analysts regarding the stock's price movement [9] Earnings Estimates and Analyst Consensus - Analysts are optimistic about PAYO's earnings prospects, with a positive trend in earnings estimate revisions, which historically correlates with stock price movements [11] - Over the last 30 days, three earnings estimates have been revised upward, leading to a 6% increase in the Zacks Consensus Estimate [12] - PAYO holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] Caution on Price Targets - While price targets are a common tool for investors, they can often mislead, and reliance solely on them may not yield favorable returns [3][10] - Analysts may set overly optimistic price targets due to business incentives, which can inflate expectations [8]

Core Viewpoint - Enliven Therapeutics, Inc. (ELVN) shows significant upside potential with a mean price target of $41.13, indicating a 102.4% increase from its current trading price of $20.32 [1][2]. Price Targets and Analyst Estimates - The mean estimate consists of eight short-term price targets with a standard deviation of $6.66, suggesting variability in analyst predictions. The lowest estimate is $33.00 (62.4% increase), while the highest is $52.00 (155.9% increase) [2]. - A low standard deviation among price targets indicates strong agreement among analysts regarding the stock's price movement direction, which can serve as a starting point for further research [9]. Earnings Estimates and Analyst Optimism - Analysts have shown growing optimism regarding ELVN's earnings prospects, as evidenced by a positive trend in earnings estimate revisions. The Zacks Consensus Estimate for the current year has increased by 5.3% over the last 30 days, with two estimates moving higher and no negative revisions [11][12]. - ELVN holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, indicating strong potential for upside in the near term [13]. Caution on Price Targets - While price targets are often sought after by investors, they can be misleading. Empirical research suggests that price targets rarely indicate actual stock price movements, and analysts may set overly optimistic targets due to business incentives [7][8][10].

Core Viewpoint - Avadel (AVDL) shares have increased by 39.7% in the past four weeks, closing at $14.85, with a mean price target of $19 indicating a potential upside of 28% [1] Price Targets and Analyst Estimates - The mean estimate consists of eight short-term price targets with a standard deviation of $2.88, where the lowest estimate is $16.00 (7.7% increase) and the highest is $24.00 (61.6% increase) [2] - A low standard deviation suggests a strong agreement among analysts regarding the stock's price movement [9] Earnings Estimates and Analyst Agreement - Analysts show strong agreement in revising AVDL's earnings estimates higher, which correlates with potential stock price increases [11] - Over the last 30 days, four earnings estimates have been revised upward, leading to a 39.4% increase in the Zacks Consensus Estimate [12] Zacks Rank and Investment Potential - AVDL holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimates [13] - While consensus price targets may not be reliable for predicting gains, they can indicate the direction of price movement [14]

Group 1 - The Cooper Companies (COO) closed at $73.48, with a 0.8% gain over the past four weeks, and analysts set a mean price target of $92.93, indicating a 26.5% upside potential [1] - The mean estimate consists of 15 short-term price targets with a standard deviation of $7.52, where the lowest estimate is $76.00 (3.4% increase) and the highest is $105.00 (42.9% increase) [2] - Analysts show strong agreement on COO's ability to report better earnings than previously predicted, which supports the view of potential upside [4][11] Group 2 - The Zacks Consensus Estimate for COO has increased by 0.1% over the past month, with one estimate going higher and no negative revisions [12] - COO holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] - While the consensus price target may not be a reliable indicator of potential gains, it does provide a directional guide for price movement [14]

Group 1 - Omnicell (OMCL) closed at $33.09, with a 14.1% gain over the past four weeks, and a mean price target of $44.4 indicating a 34.2% upside potential [1] - The average price targets range from a low of $34.00 to a high of $55.00, with a standard deviation of $9.13, suggesting variability in analyst estimates [2] - Analysts show strong agreement in revising earnings estimates higher, which correlates with potential stock price increases [4][11] Group 2 - The Zacks Consensus Estimate for the current year has increased by 33.6% over the past month, with three estimates going higher and no negative revisions [12] - OMCL holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] - While consensus price targets may not be reliable for predicting exact gains, they can indicate the direction of price movement [14]

Group 1 - Archrock Inc. (AROC) shares have increased by 3.1% over the past four weeks, closing at $24.02, with a mean price target of $31.13 indicating a potential upside of 29.6% [1] - The average of eight short-term price targets ranges from a low of $30.00 to a high of $33.00, with a standard deviation of $0.99, suggesting a consensus among analysts [2] - Analysts are optimistic about AROC's earnings prospects, as indicated by a positive trend in earnings estimate revisions, which has historically correlated with stock price movements [4][11] Group 2 - Over the last 30 days, two earnings estimates for AROC have been revised upward, leading to a 4.9% increase in the Zacks Consensus Estimate for the current year [12] - AROC holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, indicating strong potential for upside [13] - While the consensus price target may not be a reliable indicator of the magnitude of AROC's gains, it does provide a directional guide for potential price movement [14]

Remitly Global, Inc. (RELY) closed the last trading session at $19.05, gaining 12.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $27.11 indicates a 42.3% upside potential.The mean estimate comprises nine short-term price targets with a standard deviation of $3.48. While the lowest estimate of $21.00 indicates a 10.2% increase from the current price level, the most optimistic an ...

Core Viewpoint - Shares of Shoals Technologies Group (SHLS) have seen a 2.7% increase over the past four weeks, closing at $5.76, with a potential upside indicated by Wall Street analysts' mean price target of $7.25, suggesting a 25.9% increase from the current price [1] Price Targets and Analyst Estimates - The mean estimate consists of 18 short-term price targets with a standard deviation of $1.63, indicating variability among analysts; the lowest estimate is $4.00 (30.6% decline), while the highest is $11.00 (91% increase) [2] - Analysts' price targets can often mislead investors, as empirical research shows that they rarely indicate the actual price direction of a stock [7][10] - A low standard deviation in price targets suggests a high degree of agreement among analysts regarding the stock's price movement, which can serve as a starting point for further research [9] Earnings Estimates and Market Sentiment - Analysts are optimistic about SHLS's earnings prospects, as indicated by a strong consensus in revising EPS estimates higher, which correlates with near-term stock price movements [11] - Over the last 30 days, the Zacks Consensus Estimate for the current year has increased by 10.7%, with five estimates moving higher and no negative revisions [12] - SHLS holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, indicating potential upside in the near term [13]